# Nasdaq:TRDA news releases

Nasdaq:TRDA press releases distributed through HARO Newswire to the journalists who cover the beat.

- **Releases in the last 90 days:** 86
- **Web page:** https://www.helpareporter.com/news-releases/nasdaqtrda
- **RSS:** https://www.helpareporter.com/news-releases/nasdaqtrda/rss.xml

### [Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study](https://www.helpareporter.com/news-releases/independent-safety-data-monitoring-committee-recommends-initiation-of)

November 18, 2026 · Entrada Therapeutics · Nasdaq:TRDA

-- ELEVATE-45-201 Cohort 2 (10 mg/kg) enrollment complete with data expected in H1 2027 -- BOSTON, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc.
